多倍体肝细胞增多的小鼠在慢性肝损伤后再生能力维持但肝细胞癌发生减少
该研究通过可逆性敲低ANLN蛋白短暂增加小鼠肝细胞多倍体比例,再给予二乙基亚硝胺和四氯化碳诱导慢性肝损伤与癌变。结果显示多倍体肝细胞增多的小鼠肝肿瘤数目显著减少,且再生能力、基因表达及有丝分裂错误未见异常;人肝硬化结节全外显子测序未发现染色体级拷贝数变异。提示增加多倍体肝细胞可能预防肝癌。
要点
- 短暂敲低ANLN可增加小鼠肝细胞多倍体频率与程度而不永久改变ANLN水平。
- 多倍体肝细胞增多的小鼠在慢性肝损伤后肝肿瘤数目显著少于对照。
- 多倍体肝细胞维持再生能力且未见有丝分裂错误或有非肝细胞来源的再增殖。
核心结论
- 多倍体肝细胞增多的小鼠在慢性肝损伤后发生肝肿瘤更少。
- 多倍体肝细胞在慢性损伤中维持肝组织再生能力且不产生有丝分裂错误。
- 人肝硬化肝组织中未常见非整倍体,增加多倍体肝细胞或可预防肝癌。
研究设计与样本
- 研究使用Rosa-rtTa小鼠(对照)和Rosa-rtTa;TRE-short hairpin RNA小鼠,后者可逆性敲低ANLN。
- 短暂给予多西环素增加肝细胞多倍体频率和程度,随后用二乙基亚硝胺和四氯化碳诱导突变、慢性肝损伤和癌变。
- 进行部分肝切除术测试肝再生,RNA测序分析基因表达变化,谱系追踪排除非肝细胞来源再增殖,成像分裂肝细胞估计再生中有丝分裂错误频率。
- 对54例肝硬化患者肝结节进行全外显子测序以量化非整倍体。
主要发现
- 给予四氯化碳的对照小鼠肝组织倍性较未损伤肝显著增加。
- 敲低ANLN的小鼠肝细胞倍性高于生理水平,给予二乙基亚硝胺和四氯化碳后肝肿瘤显著少于对照。
- 肝细胞多倍体增加未伴随再生能力或组织适合度改变、基因表达变化或更多有丝分裂错误。
- 谱系追踪显示多倍体增加的小鼠中非肝细胞未贡献于肝再生。
- 不同倍性肝细胞有丝分裂速率相当,分裂的多倍体细胞中未见滞后染色体或微核。
临床怎么用
- 多倍体肝细胞增多与慢性肝损伤后肝肿瘤减少相关,且不损害再生能力。
- 增加多倍体肝细胞数量可能成为预防肝癌的策略。
局限性
- 研究主要基于小鼠模型,人类数据仅来自54例肝硬化肝结节的全外显子测序。
- 原文未报告多倍体肝细胞增多对肝癌发生保护作用的具体机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Thirty to 90% of hepatocytes contain whole-genome duplications, but little is known about the fates or functions of these polyploid cells or how they affect development of liver disease. We investigated the effects of continuous proliferative pressure, observed in chronically damaged liver tissues, on polyploid cells. METHODS: We studied Rosa-rtTa mice (controls) and Rosa-rtTa;TRE-short hairpin RNA mice, which have reversible knockdown of anillin, actin binding protein (ANLN). Transient administration of doxycycline increases the frequency and degree of hepatocyte polyploidy without permanently altering levels of ANLN. Mice were then given diethylnitrosamine and carbon tetrachloride (CCl4) to induce mutations, chronic liver damage, and carcinogenesis. We performed partial hepatectomies to test liver regeneration and then RNA-sequencing to identify changes in gene expression. Lineage tracing was used to rule out repopulation from non-hepatocyte sources. We imaged dividing hepatocytes to estimate the frequency of mitotic errors during regeneration. We also performed whole-exome sequencing of 54 liver nodules from patients with cirrhosis to quantify aneuploidy, a possible outcome of polyploid cell divisions. RESULTS: Liver tissues from control mice given CCl4 had significant increases in ploidy compared with livers from uninjured mice. Mice with knockdown of ANLN had hepatocyte ploidy above physiologic levels and developed significantly fewer liver tumors after administration of diethylnitrosamine and CCl4 compared with control mice. Increased hepatocyte polyploidy was not associated with altered regenerative capacity or tissue fitness, changes in gene expression, or more mitotic errors. Based on lineage-tracing experiments, non-hepatocytes did not contribute to liver regeneration in mice with increased polyploidy. Despite an equivalent rate of mitosis in hepatocytes of differing ploidies, we found no lagging chromosomes or micronuclei in mitotic polyploid cells. In nodules of human cirrhotic liver tissue, there was no evidence of chromosome-level copy number variations. CONCLUSIONS: Mice with increased polyploid hepatocytes develop fewer liver tumors following chronic liver damage. Remarkably, polyploid hepatocytes maintain the ability to regenerate liver tissues during chronic damage without generating mitotic errors, and aneuploidy is not commonly observed in cirrhotic livers. Strategies to increase numbers of polypoid hepatocytes might be effective in preventing liver cancer.
引用
- Lin YH, Zhang S, Zhu M, et al. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury. Gastroenterology. 2020. PMID: 31972235. doi:10.1053/j.gastro.2020.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。